Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group.

Saved in:
Bibliographic Details
Title: Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
Authors: Katsaounis, Panagiotis1, Kotsakis, Athanasios2, Kentepozidis, Nikolaos3, Polyzos, Aris4, Bakogeorgos, Marios3, Koinis, Filippos2, Vamvakas, Lambros2, Vardakis, Nikolaos2, Kalbakis, Kostas2, Boukovinas, Ioannis5, Varthalitis, Ioannis I.6, Prinarakis, Efthimios7, Georgoulias, Vassilis1, Souglakos, John2 georgsec@med.uoc.gr
Source: Annals of Gastroenterology. 2018, Vol. 31 Issue 1, p65-70. 6p.
Database: Academic Search Ultimate
Description
ISSN:11087471
DOI:10.20524/aog.2017.0215